CRDF logo

Cardiff Oncology (CRDF) Accounts Receivable

Annual Accounts Receivable

$288.00 K
-$483.00 K-62.65%

31 December 2023

CRDF Accounts Receivable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Accounts Receivable

$618.00 K
+$167.00 K+37.03%

30 September 2024

CRDF Quarterly Accounts Receivable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CRDF Accounts Receivable Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-62.6%+212.1%
3 y3 years-10.0%+56.5%
5 y5 years+71.6%+306.6%

CRDF Accounts Receivable High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-62.6%at low-19.8%+283.9%
5 y5 years-62.6%+71.6%-19.8%+480.8%
alltimeall time-62.6%+407.9%-19.8%+993.8%

Cardiff Oncology Accounts Receivable History

DateAnnualQuarterly
Sept 2024
-
$618.00 K(+37.0%)
June 2024
-
$451.00 K(+14.8%)
Mar 2024
-
$393.00 K(+36.5%)
Dec 2023
$288.00 K(-62.6%)
$288.00 K(+45.5%)
Sept 2023
-
$198.00 K(+23.0%)
June 2023
-
$161.00 K(-76.2%)
Mar 2023
-
$676.00 K(-12.3%)
Dec 2022
$771.00 K(+44.1%)
$771.00 K(+18.6%)
Sept 2022
-
$650.00 K(+18.0%)
June 2022
-
$551.00 K(+23.3%)
Mar 2022
-
$447.00 K(-16.4%)
Dec 2021
$535.00 K(+67.2%)
$535.00 K(+35.4%)
Sept 2021
-
$395.00 K(+28.2%)
June 2021
-
$308.00 K(+27.3%)
Mar 2021
-
$242.00 K(-24.4%)
Dec 2020
$320.00 K(+57.2%)
$320.00 K(+56.6%)
Sept 2020
-
$204.40 K(+87.0%)
June 2020
-
$109.30 K(+2.7%)
Mar 2020
-
$106.40 K(-47.7%)
Dec 2019
$203.50 K(+21.3%)
$203.50 K(+33.9%)
Sept 2019
-
$152.00 K(+24.3%)
June 2019
-
$122.30 K(+5.7%)
Mar 2019
-
$115.70 K(-31.0%)
Dec 2018
$167.80 K
$167.80 K(+30.5%)
Sept 2018
-
$128.60 K(+3.6%)
June 2018
-
$124.10 K(+8.6%)
DateAnnualQuarterly
Mar 2018
-
$114.30 K(+48.2%)
Dec 2017
$77.10 K(-23.3%)
$77.10 K(-56.7%)
Sept 2017
-
$178.10 K(+13.2%)
June 2017
-
$157.40 K(+96.0%)
Mar 2017
-
$80.30 K(-20.1%)
Dec 2016
$100.50 K(+1.8%)
$100.50 K(+18.0%)
Sept 2016
-
$85.20 K(-46.2%)
June 2016
-
$158.50 K(+156.1%)
Mar 2016
-
$61.90 K(-37.3%)
Dec 2015
$98.70 K(+74.1%)
$98.70 K(+47.3%)
Sept 2015
-
$67.00 K(-32.8%)
June 2015
-
$99.70 K(+67.8%)
Mar 2015
-
$59.40 K(+4.8%)
Dec 2014
$56.70 K(-28.2%)
$56.70 K(-9.1%)
Sept 2014
-
$62.40 K(+4.2%)
June 2014
-
$59.90 K(-53.7%)
Mar 2014
-
$129.30 K(+63.7%)
Dec 2013
$79.00 K(-53.1%)
$79.00 K(+13.5%)
Sept 2013
-
$69.60 K(+23.2%)
June 2013
-
$56.50 K(-2.8%)
Mar 2013
-
$58.10 K(-65.5%)
Dec 2012
$168.40 K(+69.9%)
$168.40 K(+31.4%)
Sept 2012
-
$128.20 K(+20.9%)
June 2012
-
$106.00 K(+38.6%)
Mar 2012
-
$76.50 K(-22.8%)
Dec 2011
$99.10 K(+32.1%)
$99.10 K
Dec 2010
$75.00 K
-

FAQ

  • What is Cardiff Oncology annual accounts receivable?
  • What is the all time high annual accounts receivable for Cardiff Oncology?
  • What is Cardiff Oncology annual accounts receivable year-on-year change?
  • What is Cardiff Oncology quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for Cardiff Oncology?
  • What is Cardiff Oncology quarterly accounts receivable year-on-year change?

What is Cardiff Oncology annual accounts receivable?

The current annual accounts receivable of CRDF is $288.00 K

What is the all time high annual accounts receivable for Cardiff Oncology?

Cardiff Oncology all-time high annual accounts receivable is $771.00 K

What is Cardiff Oncology annual accounts receivable year-on-year change?

Over the past year, CRDF annual accounts receivable has changed by -$483.00 K (-62.65%)

What is Cardiff Oncology quarterly accounts receivable?

The current quarterly accounts receivable of CRDF is $618.00 K

What is the all time high quarterly accounts receivable for Cardiff Oncology?

Cardiff Oncology all-time high quarterly accounts receivable is $771.00 K

What is Cardiff Oncology quarterly accounts receivable year-on-year change?

Over the past year, CRDF quarterly accounts receivable has changed by +$420.00 K (+212.12%)